Why the study?
Do the safety concerns regarding short-acting calcium channel blockers apply to long-acting formulations in the treatment of hypertension?
Population
Patients with hypertension or coronary disease (post-myocardial infarction)
Comparison
Calcium channel blockers vs Other antihypertensive agents or placebo
Design
Review
Authors
Loading...
Long-acting CCBs may be used safely in hypertension; leaves open prospective trials to confirm post-MI outcomes.
Do the safety concerns regarding short-acting calcium channel blockers apply to long-acting formulations in the treatment of hypertension?
The controversy surrounding the safety of short-acting calcium channel blockers should not preclude the appropriate clinical use of long-acting formulations for hypertension.
Norman M. Kaplan (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: